Here Are Big Pharma's Leading Blockbuster Makers
Morgan Stanley Keeps Their Hold Rating on BioNTech SE (BNTX)
European Equities Traded in the US as American Depositary Receipts Climb Higher in Friday Trading
European equities traded in the US as American depositary receipts were higher late Friday morning, rising 1.39% to 1,473.10 on the S&P Europe Select ADR Index. The index is set to end the week
Unusual Options Activity: CCK, PDD and Others Attract Market Bets, CCK V/OI Ratio Reaches 415.8
EST Jul 11th Morning Delivery - In the last two hours of trading, 8 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Thursday Trading
European equities traded in the US as American depositary receipts were trending slightly higher late Thursday morning, rising 0.19% to 1,460.27 on the S&P Europe Select ADR Index.From continental
CureVac Announced The Latest Trial Dates For Its Ongoing Patent Litigation Against Pfizer/BioNTech In Multiple Geographies, Including The U.S., UK, And Germany
New trial date for U.S. patent litigation set for March 3, 2025, following settlement with Acuitas Therapeutics. First instance decision on validity of EP 3 708 668 B1 (split poly-A tail technology)
Express News | CureVac Provides Update on Trial Dates for Patent Litigation Across Multiple Geographies Against Pfizer/BioNTech
Pfizer R&D Head Mikael Dolsten to Depart
Morgan Stanley Sticks to Their Hold Rating for BioNTech SE (BNTX)
European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading
European equities traded in the US as American depositary receipts were trending higher late Wednesday morning, rising 0.6% to 1,436.74 on the S&P Europe Select ADR Index. From continental Europe, the
Pfizer-BioNTech, Moderna Set to Appeal Mixed UK Ruling in COVID-19 Vaccine Patent Case
Moderna (0QF.F) and its rivals Pfizer (PFE.F) and BioNTech (22UA.F) are considering appeals after London's High Court handed down a mixed ruling in their patent dispute relating to the mRNA technology behind their COVID-19 vaccines.
Unusual Options Activity: WBD, BNTX and Others Attract Market Bets, WBD V/OI Ratio Reaches 921.1
EST Jul 1st Closing Delivery - In the last three hours of trading, 4 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.
Morgan Stanley Maintains BioNTech(BNTX.US) With Hold Rating, Maintains Target Price $101
Morgan Stanley analyst Terence Flynn maintains $BioNTech(BNTX.US)$ with a hold rating, and maintains the target price at $101.According to TipRanks data, the analyst has a success rate of 65.0% and a
Morgan Stanley Sticks to Its Hold Rating for BioNTech SE (BNTX)
Andreas & Thomas Struengmann Award Honors HAYA Therapeutics Co-founders as Inaugural Winners
The award jury selected Samir Ounzain, PhD and Daniel Blessing, PhD, the two co-founders of HAYA Therapeutics, as the winners from an outstanding finalist group of life science entrepreneurs Represe
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Friday Trading
European equities traded in the US as American depositary receipts were moving slightly higher late Friday morning, rising 0.12% to 1,424.97 on the S&P Europe Select ADR Index. However, the gain likel
Pfizer (PFE), BioNTech's Updated COVID-19 Jab Gets CHMP Nod
CHMP Recommends Authorisation for Pfizer-BioNTech's Covid-19 Vaccine
AbbVie/Genmab's Epkinly FDA Approval Is A Positive Step, Analyst Says Additional Expansion Opportunities Underway
On Wednesday, the FDA approved Epkinly (epcoritamab-bysp) as the first and only T-cell-engaging bispecific antibody administered subcutaneously for adults with relapsed or refractory follicular lympho
Express News | Pfizer and BioNTech Receive Positive Chmp Opinion for Omicron Jn.1-Adapted Covid-19 Vaccine in the European Union